°øÁö : µµÄìÁõ±Ç°Å·¡¼Ò JASDAQ ½ºÅÄ´Ùµå ½ÃÀå ½Å±Ô »óÀå °ü·Ã ¾È³»

Global Information
ȸ»ç¼Ò°³ | ¹®ÀÇ | ºñ±³¸®½ºÆ®

Çʸ®ÇÉÀÇ ÀǾàǰ ¹× ÀÇ·á ½ÃÀå

Philippines Pharmaceuticals & Healthcare

¸®¼­Ä¡»ç Fitch Solutions, Inc.
¹ßÇàÁ¤º¸ ¿¬°£±¸µ¶ »óǰ ÄÚµå 974338
ÆäÀÌÁö Á¤º¸ ¿µ¹® 63 Pages
°¡°Ý
US $ 1,415 £Ü 1,615,000 PDF (Single User License) - Includes 3 FREE Quarterly Updates


Çʸ®ÇÉÀÇ ÀǾàǰ ¹× ÀÇ·á ½ÃÀå Philippines Pharmaceuticals & Healthcare
¹ßÇàÁ¤º¸ : ÆäÀÌÁö Á¤º¸ : ¿µ¹® 63 Pages

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹®¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹®¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

±¹¹Î Àüü º¸ÇèÀ» ´Þ¼ºÇÑ´Ù´Â Çʸ®ÇÉÀÇ ¾ß¸ÁÀº Äڷγª¹ÙÀÌ·¯½º ÆÒµ¥¹Í¿¡ ÀÇÇØ ÁöüµÉ °ÍÀÔ´Ï´Ù. º¸°ÇºÎ´Â ÇöÀç ¹ÙÀÌ·¯½º¿ÍÀÇ ÀüÀï¿¡ ÃÊÁ¡À» ¸ÂÃß°í Àֱ⠶§¹®¿¡ 2020³â ÀǾàǰ ÁöÃâ ¼ºÀå ¿¹ÃøÀ» ¼öÁ¤Çß½À´Ï´Ù. ÇÑÆí, Á¦¾à¾÷ü »çÀÌ¿¡¼­´Â ÃÖ´ë ¼Ò¸Å°¡°Ý(MRP) Á¦µµÀÇ ºÒÅõ¸í¼º ¶§¹®¿¡ ´Ü±âÀûÀ¸·Î´Â ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÞÀ» °ÍÀÌÁö¸¸, Àú°¡ Çõ½ÅÀû ÀǾàǰÀÇ Àå±âÀû ¿µÇâ¿¡ ÀÇÇØ ÆÇ¸Å·® Áõ°¡¿Í ½ÃÀå °æÀïÀÌ ½ÉÇØÁ®¼­ ÃÖÁ¾ÀûÀ¸·Î´Â °¡°Ý ÅëÁ¦°¡ ÇàÇØÁú °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

  • Key View
  • COVID-19ÀÇ ¿µÇâ
  • SWOT ºÐ¼®
  • ¾÷°è ¿¹Ãø
  • ÀǾàǰ ½ÃÀå ¿¹Ãø
  • ÀÇ·á ½ÃÀå ¿¹Ãø
  • ó¹æ¾à ½ÃÀå ¿¹Ãø
  • ƯÇã ÀǾàǰ ½ÃÀå ¿¹Ãø
  • Á¦³×¸¯ ÀǾàǰ ½ÃÀå ¿¹Ãø
  • OTC ÀǾàǰ ½ÃÀå ¿¹Ãø
  • ÀǾàǰ ¹«¿ª ¿¹Ãø
  • ¾÷°è ¸®½ºÅ©/º¸»ó Áö¼ö
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Çõ½ÅÀû ÀǾàǰ ¸®½ºÅ©/º¸»ó Áö¼ö
  • Çõ½ÅÀû ÀǾàǰ ¸®½ºÅ©/º¸»ó Áö¼ö
  • ±ÔÁ¦ ¹ßÀü
  • ±ÔÁ¦ ¸®ºä
  • ½ÃÀå »óȲ °³¿ä

°æÀï ±¸µµ

  • ±â¾÷ °³¿ä
  • GlaxoSmithKline
  • Novartis
  • Çʸ®ÇÉÀÇ Àα¸Åë°è Àü¸Á
  • ¿ë¾îÁý
  • Á¶»ç ¹æ¹ý
LSH 20.12.17

Key View: This Philippines' ambition to achieve universal health coverage will be delayed by the coronavirus pandemic as much of the Department of Health's focus is currently on battling the effects of the virus, and as such we have revised our forecast for growth of pharmaceutical spending in 2020. However, despite uncertainty among drug manufacturers relating to the maximum retail price (MRP) scheme executive order and the likelihood of negative short-term effects, the long term impact of lower priced innovative medicines should encourage higher volume sales and greater competition in the market, which would eventually make these planned price controls a positive for the market.

Table of Contents

  • Key View
  • Philippines Pharmaceutical & Healthcare Covid-19 Impact
  • SWOT
  • Industry Forecast
  • Pharmaceutical Market Forecast
  • Healthcare Market Forecast
  • Prescription Drug Market Forecast
  • Patented Drug Market Forecast
  • Generic Drug Market Forecast
  • OTC Medicine Market Forecast
  • Pharmaceutical Trade Forecast
  • Industry Risk/Reward Index
  • Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
  • Innovative Pharmaceuticals Risk/Reward Index
  • Regulatory Development
  • Regulatory Review
  • Market Overview

Competitive Landscape

  • Company Profile
  • GlaxoSmithKline
  • Novartis
  • Philippines Demographic Outlook
  • Pharmaceuticals & Healthcare Glossary
  • Pharmaceuticals & Healthcare Methodology
Back to Top
ÀüÈ­ ¹®ÀÇ
F A Q